Cancer Research Meeting Calendar Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tian, F.
Right arrow Articles by Roberts, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tian, F.
Right arrow Articles by Roberts, A. B.
[Cancer Research 63, 8284-8292, December 1, 2003]
© 2003 American Association for Cancer Research

Regular Articles

Reduction in Smad2/3 Signaling Enhances Tumorigenesis but Suppresses Metastasis of Breast Cancer Cell Lines

Fang Tian, Stacey DaCosta Byfield, W. Tony Parks, Stephen Yoo, Angelina Felici, Binwu Tang, Ester Piek, Lalage M. Wakefield and Anita B. Roberts

Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Bethesda, Maryland

The role of transforming growth factor ß in breast cancer is controversial with tumor suppressor and pro-oncogenic activities having been demonstrated. To address whether the same or different signal transduction pathways mediate these opposing activities, we manipulated the Smad2/3 signaling pathway in cells of common origin but differing degrees of malignancy derived from MCF10A human breast cells. We show that interference with endogenous Smad2/3 signaling enhances the malignancy of xenografted tumors of premalignant and well-differentiated tumor cells but strongly suppresses lung metastases of more aggressive carcinoma cells after tail vein injection. Overexpression of Smad3 in the same cells has opposite effects. The data demonstrate that the Smad2/3 signaling pathway mediates tumor suppressor and prometastatic signals, depending on the cellular context.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
K. Matsuzaki, C. Kitano, M. Murata, G. Sekimoto, K. Yoshida, Y. Uemura, T. Seki, S. Taketani, J.-i. Fujisawa, and K. Okazaki
Smad2 and Smad3 Phosphorylated at Both Linker and COOH-Terminal Regions Transmit Malignant TGF-{beta} Signal in Later Stages of Human Colorectal Cancer
Cancer Res., July 1, 2009; 69(13): 5321 - 5330.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Yang, R. Wahdan-Alaswad, and D. Danielpour
Critical Role of Smad2 in Tumor Suppression and Transforming Growth Factor-{beta}-Induced Apoptosis of Prostate Epithelial Cells
Cancer Res., March 15, 2009; 69(6): 2185 - 2190.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Zhao, S. Ammanamanchi, M. Brattain, L. Cao, A. Thangasamy, J. Wang, and J. W. Freeman
Smad4-dependent TGF-{beta} Signaling Suppresses RON Receptor Tyrosine Kinase-dependent Motility and Invasion of Pancreatic Cancer Cells
J. Biol. Chem., April 25, 2008; 283(17): 11293 - 11301.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. C. Willis and Z. Borok
TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L525 - L534.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. J. Laping, J. I. Everitt, K. S. Frazier, M. Burgert, M. J. Portis, C. Cadacio, L. I. Gold, and C. L. Walker
Tumor-Specific Efficacy of Transforming Growth Factor-{beta}RI Inhibition in Eker Rats
Clin. Cancer Res., May 15, 2007; 13(10): 3087 - 3099.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. J. Galliher and W. P. Schiemann
Src Phosphorylates Tyr284 in TGF-{beta} Type II Receptor and Regulates TGF-{beta} Stimulation of p38 MAPK during Breast Cancer Cell Proliferation and Invasion
Cancer Res., April 15, 2007; 67(8): 3752 - 3758.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
P. C. Gray, G. Shani, K. Aung, J. Kelber, and W. Vale
Cripto Binds Transforming Growth Factor {beta} (TGF-{beta}) and Inhibits TGF-{beta} Signaling
Mol. Cell. Biol., December 15, 2006; 26(24): 9268 - 9278.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Bandyopadhyay, J. K. Agyin, L. Wang, Y. Tang, X. Lei, B. M. Story, J. E. Cornell, B. H. Pollock, G. R. Mundy, and L.-Z. Sun
Inhibition of Pulmonary and Skeletal Metastasis by a Transforming Growth Factor-{beta} Type I Receptor Kinase Inhibitor.
Cancer Res., July 1, 2006; 66(13): 6714 - 6721.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
H. J. Lee, A. Wislocki, C. Goodman, Y. Ji, R. Ge, H. Maehr, M. Uskokovic, M. Reiss, and N. Suh
A Novel Vitamin D Derivative Activates Bone Morphogenetic Protein Signaling in MCF10 Breast Epithelial Cells
Mol. Pharmacol., June 1, 2006; 69(6): 1840 - 1848.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Deckers, M. van Dinther, J. Buijs, I. Que, C. Lowik, G. van der Pluijm, and P. ten Dijke
The Tumor Suppressor Smad4 Is Required for Transforming Growth Factor {beta}-Induced Epithelial to Mesenchymal Transition and Bone Metastasis of Breast Cancer Cells
Cancer Res., February 15, 2006; 66(4): 2202 - 2209.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
S. G. Kim, H.-A. Kim, H.-S. Jong, J.-H. Park, N. K. Kim, S. H. Hong, T.-Y. Kim, and Y.-J. Bang
The Endogenous Ratio of Smad2 and Smad3 Influences the Cytostatic Function of Smad3
Mol. Biol. Cell, October 1, 2005; 16(10): 4672 - 4683.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Kang, W. He, S. Tulley, G. P. Gupta, I. Serganova, C.-R. Chen, K. Manova-Todorova, R. Blasberg, W. L. Gerald, and J. Massague
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway
PNAS, September 27, 2005; 102(39): 13909 - 13914.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. E. Burdette, J. S. Jeruss, S. J. Kurley, E. J. Lee, and T. K. Woodruff
Activin A Mediates Growth Inhibition and Cell Cycle Arrest through Smads in Human Breast Cancer Cells
Cancer Res., September 1, 2005; 65(17): 7968 - 7975.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
A. Moustakas and C.-H. Heldin
Non-Smad TGF-{beta} signals
J. Cell Sci., August 15, 2005; 118(16): 3573 - 3584.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
C. H. Stuelten, S. D. Byfield, P. R. Arany, T. S. Karpova, W. G. Stetler-Stevenson, and A. B. Roberts
Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-{alpha} and TGF-{beta}
J. Cell Sci., May 15, 2005; 118(10): 2143 - 2153.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. K. Kamaraju and A. B. Roberts
Role of Rho/ROCK and p38 MAP Kinase Pathways in Transforming Growth Factor-{beta}-mediated Smad-dependent Growth Inhibition of Human Breast Carcinoma Cells in Vivo
J. Biol. Chem., January 14, 2005; 280(2): 1024 - 1036.
[Abstract] [Full Text] [PDF]

Home page
 CROBMHome page
S.S. Prime, M. Davies, M. Pring, and I.C. Paterson
THE ROLE OF TGF-{beta} IN EPITHELIAL MALIGNANCY AND ITS RELEVANCE TO THE PATHOGENESIS OF ORAL CANCER (PART II)
Critical Reviews in Oral Biology & Medicine, November 1, 2004; 15(6): 337 - 347.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. G. Li, S.-L. Lu, M.-X. Zhang, C. Deng, and X.-J. Wang
Smad3 Knockout Mice Exhibit a Resistance to Skin Chemical Carcinogenesis
Cancer Res., November 1, 2004; 64(21): 7836 - 7845.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Tian, S. D. Byfield, W. T. Parks, C. H. Stuelten, D. Nemani, Y. E. Zhang, and A. B. Roberts
Smad-Binding Defective Mutant of Transforming Growth Factor {beta} Type I Receptor Enhances Tumorigenesis but Suppresses Metastasis of Breast Cancer Cell Lines
Cancer Res., July 1, 2004; 64(13): 4523 - 4530.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.